Gram-negative bacteria

MALVERN, PA — Venatorx Pharmaceuticals this week announced a comprehensive update about cefepime-taniborbactam, the Company’s intravenous beta-lactam / beta-lactamase inhibitor (BL/BLI) combination antibiotic that is being developed for the treatment …